We previously showed that the decreased PAI-1 level is a significant risk factor for COVID-19-related death in severely ill patients [27], reflecting the exhaustion of compensatory mechanisms for hyperactivation of the plasminogen activator system in COVID-19. This evidence concerns the gene SERPINE1 and COVID-19.